Cary, NC, United States of America

Paul Christopher Fritch



Average Co-Inventor Count = 3.6

ph-index = 4

Forward Citations = 49(Granted Patents)


Location History:

  • Durham, NC (US) (2002)
  • Cary, NC (US) (2007 - 2014)

Company Filing History:


Years Active: 2002-2014

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovations of Paul Christopher Fritch

Introduction

Paul Christopher Fritch is a notable inventor based in Cary, NC (US). He has made significant contributions to the field of ion channel inhibitors, holding a total of 5 patents. His work has implications in various therapeutic areas, showcasing his expertise and innovative spirit.

Latest Patents

Fritch's latest patents include groundbreaking inventions such as "Inhibitors of Ion Channels," which is directed to compounds of Formula I where R, R, B, and Z are defined. Another significant patent is "Heterocyclic Sulfonamides as Inhibitors of Ion Channels," which focuses on compounds of a specific formula where R, B, and Z are also defined. These inventions highlight his commitment to advancing medical science through innovative solutions.

Career Highlights

Throughout his career, Fritch has worked with prominent companies such as Icagen, Inc. and Pfizer Corporation. His experience in these organizations has allowed him to develop and refine his inventions, contributing to the advancement of pharmaceutical research and development.

Collaborations

Fritch has collaborated with notable individuals in his field, including Grant Andrew McNaughton-Smith and George Salvatore Amato. These partnerships have likely enriched his work and expanded the impact of his inventions.

Conclusion

Paul Christopher Fritch is a distinguished inventor whose work in ion channel inhibitors has led to multiple patents and significant advancements in medical research. His collaborations and career experiences further enhance his contributions to the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…